Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Moolec Science ( (MLEC) ) has issued an update.
Moolec Science SA held its virtual Annual General Meeting of shareholders on May 13, 2026, with 71.24% of the 2,080,437 ordinary shares entitled to vote represented, establishing a valid quorum. Shareholders approved the consolidated financial statements and the independent auditor’s report for the financial year ended June 30, 2025.
At the same meeting, investors re-elected directors Diego Abelleyra Llodra, Oscar Leon Bentancor, Romualdo Varela and Daniel Core for terms lasting until the next AGM or until successors are appointed. Shareholders also ratified the reappointment of Price Waterhouse & Co. S.R.L. as the company’s independent registered public accounting firm for the fiscal year ending June 30, 2026, reinforcing continuity in both board oversight and external audit arrangements.
Spark’s Take on MLEC Stock
According to Spark, TipRanks’ AI Analyst, MLEC is a Neutral.
The score is held down primarily by weak financial health—large losses, continued cash burn, and a materially weakened capital structure with negative equity and elevated debt. Technicals are moderately supportive with improving intermediate momentum, but valuation remains constrained by unprofitability and no dividend support.
To see Spark’s full report on MLEC stock, click here.
More about Moolec Science
Moolec Science SA is a Cayman Islands–incorporated foreign private issuer listed on Nasdaq under the ticker MLEC. The company operates in the agri-food and biotechnology sector, focusing on molecular farming technologies to produce animal proteins in plants for use in food and ingredients markets.
Average Trading Volume: 478,492
Technical Sentiment Signal: Sell
Current Market Cap: $6.38M
Find detailed analytics on MLEC stock on TipRanks’ Stock Analysis page.